HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

Andere talen Hansoh Pharmaceutical Group Company Limited

Aandelen

3692

KYG549581067

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:08:05 31-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
16,06 ^HKD	+0,38%		-3,49%	+1,90%

30/04	Hansoh Pharmaceutical's winst voor 2023 stijgt met 27%	MT
29/04	Hansoh Pharmaceutical Group Company Limited kondigt wijzigingen aan in de leiding, met ingang van 29 april 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Hansoh Pharmaceutical’s 2023 Profit Up 27%	30/04
Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024	29/04
Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug	03/04
Hansoh Pharmaceutical Group Company Limited, Jiangsu Hansoh Pharmaceutical Group Company Limited and Shanghai Hansoh Biomedical Technology Company Limited Receives Grant of A Clinical Trial Notice Issued by the National Medical Products Administration of the People's Republic of China to Be Used for the Treatment of Advanced Non-Small Cell Lung Cancer	03/04
Hansoh Pharmaceutical Group Company Limited Recommends Final Dividend, Payable on July 17, 2024	26/03
Hansoh Pharmaceutical Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED : Nomura n'est plus à l'achat	14/03
Hansoh Pharmaceutical Gets Nod to Trial Nephropathy Treatment Capsules	08/02
Hansoh Pharmaceutical Buys Back 3 Million Shares	31/01
Fed, China Property Outlooks Roil Asian Stock Markets	30/01
Hansoh Secures Chinese Nod For Clinical Trial Of Anti-Diabetes Drug	23/01
China Outlook, Tech Rally Roils Asian Stock Markets	19/01
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of HS-10509 Tablets	17/01
Federal Reserve Outlook Mutes Asian Stock Markets	05/01
GSK plc Enters Exclusive License Agreement with Hansoh for HS-20093	20/12
Games Workshop seals Amazon deal for Warhammer 40,000	18/12
GSK looks for deals in China as rebuilds relationship	17/12
Shanghai Hansoh Biomedical Technology Company Limited and Jiangsu Hansoh Pharmaceutical Group Company Limited Receives Clinical Trial Notice	10/11
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of Hs-20106 Injections	19-10-23
Rising Interest Rates Blunt Asian Stock Markets	26-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Hansoh Pharmaceutical Group Company Limited

Aandelen

3692

KYG549581067

Andere talen

Filters